Oncology CRO Oncotherapeutics Presents at ASH 2011 Annual Meeting

Oncotherapeutics, an oncology specific Contract Research Organization (CRO) specializing in the oversight and management of…

read more

The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo

Leuk Res. 2011 Mar;35(3):373-9. doi: 10.1016/j.leukres.2010.06.026. Epub 2010 Jul 21. Sanchez E, Shen J, Steinberg…

read more

Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients

The results of this landmark study should be welcomed news to cancer patients across the…

read more

IMBCR Identifies New Treatments for Myeloma in 2015!

First, we have made much progress on our new protein marker called B-cell maturation antigen…

read more
Previous Posts